Congenital CMV
Maternal viral and immune dynamics, placental passage, fetal exposure, model comparison, sensitivity, calibration, and surrogate modeling.
Duke Postdoctoral Research · Ongoing methodological development
I develop quantitative links across biological scales and study systems. The program combines maternal-placental-fetal CMV modeling with relaxed optimal transport for mapping immune-cell populations between human and non-human primate data.
One program, two translation problems
Congenital CMV transmission spans maternal immune dynamics, placental infection and barrier function, and fetal exposure. Cross-species immune studies add a second translation problem: cell proportions, technical effects, marker panels, and even cell subsets can differ between humans and non-human primates.
The unifying contribution is a disciplined modeling process. I compare alternative mechanisms, identify what available observations can constrain, and retain ambiguity when the evidence does not support a forced match or a single preferred model.
Maternal viral and immune dynamics, placental passage, fetal exposure, model comparison, sensitivity, calibration, and surrogate modeling.
Shared-marker preprocessing, independent clustering, Gaussian summaries, relaxed optimal transport, bidirectional mapping, and uncertainty diagnostics.
Module 1 · Congenital CMV
Ordinary differential equations represent viral and immune dynamics in maternal blood. Spatial or agent-based components describe placental infection and passage. Stochastic components represent variation in fetal exposure. Clinical cohort measurements and placental-organoid experiments provide complementary constraints.
These figures are model diagnostics, not validated vaccine-efficacy predictions. Claims about maternal protection or fetal transmission should wait for project-specific calibration and external validation.
Model selection and computation
I compare candidate mechanistic formulations before choosing a calibration target, use sensitivity analysis to identify influential and weakly identifiable parameters, and evaluate surrogate models for reducing simulation cost.
Gaussian Process Regression, gradient-boosted trees with Bayesian optimization, and physics-informed neural networks are considered for specific tasks. They are not interchangeable. The choice depends on data volume, computational cost, uncertainty needs, and whether biological structure must remain explicit.
Module 2 · Cross-species immune mapping
Marker panels, cell proportions, and technical effects differ across species, so nearest-centroid matching can produce misleading one-to-one correspondences. The workflow uses shared-marker preprocessing, independent clustering, covariance-regularized Gaussian representations, Wasserstein distances, and optimal transport with relaxed marginals.
The mapping is bidirectional and reports top probability, entropy, and unmatched mass. These diagnostics show where a correspondence is concentrated, ambiguous, or unsupported.
Takeaway
The goal is not to present one preferred simulator or one forced cross-species map. It is to decide which model is appropriate, what the data can identify, and where uncertainty should remain visible.
View Duke postdoctoral role